Trinity Biotech Operating Expenses Growth & History (TRIB)
Trinity Biotech's operating expenses was $28.3M for fiscal 2025.
View full Trinity Biotech company overviewTrinity Biotech annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $28.3M | −$14.3M | −33.57% |
| 2024 | 2024-12-31 | $42.6M | −$3.9M | −8.36% |
| 2023 | 2023-12-31 | $46.5M | $9.9M | +26.98% |
| 2022 | 2022-12-31 | $36.6M | $7.1M | +24.06% |
| 2021 | 2021-12-31 | $29.5M | −$19.0M | −39.14% |
| 2020 | 2020-12-31 | $48.5M | −$13.7M | −22.07% |
| 2019 | 2019-12-31 | $62.2M | $556,000 | +0.90% |
| 2018 | 2018-12-31 | $61.7M | −$17.9M | −22.48% |
| 2017 | 2017-12-31 | $79.6M | −$3.8M | −4.53% |
| 2016 | 2016-12-31 | $83.3M | $50.3M | +152.48% |
| 2015 | 2015-12-31 | $33.0M | — | — |
Trinity Biotech quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $13.4M | — | — |
| Q2 2018 | 2018-06-30 | $9.1M | $95,000 | +1.06% |
| Q2 2017 | 2017-06-30 | $9.0M | — | — |
Trinity Biotech operating expenses trends
Over the last five fiscal years, Trinity Biotech's operating expenses decreased from $48.5M to $28.3M, a change of −$20.2M. The latest reported quarter, Q4 2024, shows $13.4M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech source filings ↗